| scholarly article | Q13442814 |
| P2093 | author name string | Robert E Bristow | |
| Ling Chen | |||
| David G Mutch | |||
| Matthew A Powell | |||
| William A Cliby | |||
| J Philip Miller | |||
| Phillip Y Roland | |||
| Noor Al-Hammadi | |||
| P2860 | cites work | Centralisation of services for gynaecological cancer | Q24201268 |
| Cancer statistics, 2012 | Q27860574 | ||
| Impact of hospital volume on operative mortality for major cancer surgery | Q34482407 | ||
| Trends in treatment of advanced epithelial ovarian cancer in the Medicare population. | Q35013736 | ||
| The National Cancer Data Base report on ovarian cancer treatment in United States hospitals | Q36832486 | ||
| Variations in institutional infrastructure, physician specialization and experience, and outcome in ovarian cancer: a systematic review | Q37319775 | ||
| Hospital and surgeon volume in relation to survival after esophageal cancer surgery in a population-based study | Q38428202 | ||
| The national cancer data base: past, present, and future | Q42938244 | ||
| The effect of hospital operative volume, residual tumor and first-line chemotherapy on survival of ovarian cancer - a prospective nation-wide study in Finland | Q43288731 | ||
| The National Cancer Database report on advanced-stage epithelial ovarian cancer: impact of hospital surgical case volume on overall survival and surgical treatment paradigm | Q43806757 | ||
| Trends in surgery and chemotherapy for women diagnosed with ovarian cancer in the United States | Q44820275 | ||
| Ovarian cancer: changes in patterns at diagnosis and relative survival over the last three decades. | Q46792064 | ||
| Ovarian cancer, version 3.2012. | Q47562494 | ||
| Influence of hospital procedure volume on ovarian cancer survival in Japan, a country with low incidence of ovarian cancer | Q47964651 | ||
| Improved short-term survival for advanced ovarian, tubal, and peritoneal cancer patients operated at teaching hospitals | Q58618983 | ||
| The effect of centralization of primary surgery on survival in ovarian cancer patients | Q73916651 | ||
| FIGO staging of gynecologic cancer. 1994-1997 FIGO Committee on Gynecologic Oncology. International Federation of Gynecology and Obstetrics | Q78067870 | ||
| Ovarian cancer: patterns of surgical care across the United States | Q79148248 | ||
| Ten years' experience with centralized surgery of ovarian cancer in one health region in Norway | Q82491211 | ||
| Specialized and high-volume care leads to better outcomes of ovarian cancer treatment in the Netherlands | Q83171533 | ||
| One of the most important aspects of health care delivery for cancer patients involves the need for centralization of treatment to high quality centers. Introduction | Q83318137 | ||
| Surgical outcomes and national comprehensive cancer network compliance in advanced ovarian cancer surgery in a low volume military treatment facility | Q87123589 | ||
| P433 | issue | 1 | |
| P407 | language of work or name | English | Q1860 |
| P921 | main subject | United States of America | Q30 |
| ovarian cancer | Q172341 | ||
| P304 | page(s) | 11-17 | |
| P577 | publication date | 2014-10-29 | |
| P1433 | published in | Gynecologic Oncology | Q5625182 |
| P1476 | title | Ovarian cancer in the United States: contemporary patterns of care associated with improved survival | |
| P478 | volume | 136 |
| Q87266956 | "Less is more:" The harms of overtreatment in early ovarian cancer |
| Q102151297 | Adherence to treatment guidelines as a major determinant of survival disparities between black and white patients with ovarian cancer |
| Q49887274 | Adherence to treatment recommendations and outcomes for women with ovarian cancer at first recurrence |
| Q88658353 | Adjuvant therapy in major salivary gland cancers: Analysis of 8580 patients in the National Cancer Database |
| Q102995392 | An increase in multi-site practices: The shifting paradigm for gynecologic cancer care delivery |
| Q47636216 | Are patients willing to travel for better ovarian cancer care? |
| Q40087667 | Association of Hospital Volume and Quality of Care With Survival for Ovarian Cancer |
| Q38617648 | Associations between residual disease and survival in epithelial ovarian cancer by histologic type |
| Q47864518 | BTG3 Overexpression Suppresses the Proliferation and Invasion in Epithelial Ovarian Cancer Cell by Regulating AKT/GSK3β/β-Catenin Signaling |
| Q64237406 | Can complete blood count inflammatory parameters in epithelial ovarian cancer contribute to prognosis? - a survival analysis |
| Q49203345 | Cancer and treatment-related symptoms are associated with mobility disability in women with ovarian cancer: A cross-sectional study |
| Q40729852 | Centralized primary care of advanced ovarian cancer improves complete cytoreduction and survival - A population-based cohort study |
| Q56334821 | Cervical cancer care in rural Virginia: The impact of distance from an academic medical center on outcomes & the role of non-specialized radiation centers |
| Q26747284 | Clinical Trial Accrual: Obstacles and Opportunities |
| Q37729985 | Complications from Surgeries Related to Ovarian Cancer Screening |
| Q37406838 | Diagnostic usefulness of the Risk of Ovarian Malignancy Algorithm using the electrochemiluminescence immunoassay for HE4 and the chemiluminescence microparticle immunoassay for CA125. |
| Q26768263 | Disparities in Gynecological Malignancies |
| Q47368363 | Disparities in ovarian cancer survival in the United States (2001-2009): Findings from the CONCORD-2 study. |
| Q58557620 | Downregulation of miR-145-5p in cancer cells and their derived exosomes may contribute to the development of ovarian cancer by targeting CT |
| Q64101330 | Enhancing ovarian cancer care: a systematic review of guideline adherence and clinical variation |
| Q52616399 | Exploring the impact of income and race on survival for women with advanced ovarian cancer undergoing primary debulking surgery at a high-volume center. |
| Q33605208 | Factors Predicting Use of Neoadjuvant Chemotherapy Compared With Primary Debulking Surgery in Advanced Stage Ovarian Cancer-A National Cancer Database Study |
| Q46983745 | Factors associated with delivery of neoadjuvant chemotherapy in women with advanced stage ovarian cancer |
| Q35906593 | Gene expression profiling of ovarian carcinomas and prognostic analysis of outcome. |
| Q39013118 | Geographic access to gynecologic cancer care in the United States |
| Q55716532 | Identification of common differentially-expressed miRNAs in ovarian cancer cells and their exosomes compared with normal ovarian surface epithelial cell cells. |
| Q64064070 | Identification of exosomal and non‑exosomal microRNAs associated with the drug resistance of ovarian cancer |
| Q52673384 | Impact of hospital volume on racial disparities and outcomes for endometrial cancer. |
| Q98568369 | Impact of provider volume on front-line chemotherapy guideline compliance and overall survival in elderly patients with advanced ovarian cancer |
| Q36794300 | Is It Time to Centralize Ovarian Cancer Care in the United States? |
| Q86441139 | Measuring ovarian cancer care: why are we still failing? |
| Q90127179 | MicroRNA-204-5p Inhibits Ovarian Cancer Cell Proliferation by Down-Regulating USP47 |
| Q53054061 | Neoadjuvant Chemotherapy for Newly Diagnosed, Advanced Ovarian Cancer: Society of Gynecologic Oncology and American Society of Clinical Oncology Clinical Practice Guideline. |
| Q39242605 | Neoadjuvant Systemic Therapy Use for Younger Patients with Breast Cancer Treated in Different Types of Cancer Centers Across the United States. |
| Q33626973 | Neoadjuvant chemotherapy for newly diagnosed, advanced ovarian cancer: Society of Gynecologic Oncology and American Society of Clinical Oncology Clinical Practice Guideline |
| Q88195269 | Ovarian cancer |
| Q40342636 | Ovarian cancer outcomes: Predictors of early death. |
| Q42696855 | Patient-centered research priorities in ovarian cancer: A systematic review of potential determinants of guideline care |
| Q90632434 | Patterns and predictors of genetic referral among ovarian cancer patients at a National Cancer Institute-Comprehensive Cancer Center |
| Q91470950 | Quality indicators in gynecologic oncology |
| Q56349488 | Quality of life, symptoms and care needs in patients with persistent or recurrent platinum-resistant ovarian cancer: An NRG Oncology/Gynecologic Oncology Group study |
| Q91996356 | Race, Socioeconomic Status, and Health-Care Access Disparities in Ovarian Cancer Treatment and Mortality: Systematic Review and Meta-Analysis |
| Q92570015 | Regionalization of care for women with ovarian cancer |
| Q89568447 | Risk factors for early death among ovarian cancer patients: a nationwide cohort study |
| Q40351106 | Risk-prediction model of severe postoperative complications after primary debulking surgery for advanced ovarian cancer |
| Q26801358 | Role of aggressive surgical cytoreduction in advanced ovarian cancer |
| Q33850463 | Ten Important Considerations for Ovarian Cancer Screening |
| Q91067850 | The association between facility case volume and overall survival in patients with metastatic renal cell carcinoma in the targeted therapy era |
| Q36093253 | The care center influences the management of lymphoma patients in a universal health care system: an observational cohort study |
| Q33639932 | The effect of time on racial differences in epithelial ovarian cancer (OVCA) diagnosis stage, overall and by histologic subtypes: a study of the National Cancer Database. |
| Q87988958 | Time for centralizing patients with ovarian cancer: what are we waiting for? |
| Q38861948 | Trends and factors associated with radical cytoreductive surgery in the United States: A case for centralized care |
| Q39472177 | Trends in hospice discharge, documented inpatient palliative care services and inpatient mortality in ovarian carcinoma |
| Q38857898 | Trends in the receipt of guideline care and survival for women with ovarian cancer: A population-based study |
| Q36011137 | Use and Effectiveness of Intraperitoneal Chemotherapy for Treatment of Ovarian Cancer |
| Q33816983 | Use and Effectiveness of Neoadjuvant Chemotherapy for Treatment of Ovarian Cancer |
| Q47297885 | Values and worries of ovarian cancer patients |
| Q38861953 | Variation in neoadjuvant chemotherapy utilization for epithelial ovarian cancer at high volume hospitals in the United States and associated survival. |
Search more.